Glaucoma: Overview
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Open Angle Glaucoma: Treatment
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Angle Closure Glaucoma: Treatment
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 19, 2026

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
Published on: June 3, 2018
N B Costa1, C T X Silva2, A B Frare2
1Pontifícia Universidade Católica de Goiás, Goiânia, GO, Brasil nath_bc3@hotmail.com.
The CYP1A1m1 polymorphism, linked to DNA damage, was more common in Brazilian primary open-angle glaucoma patients than controls. This genetic variation may increase glaucoma risk by affecting xenobiotic metabolism.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: